From Dr. Laura Lubbers <[email protected]>
Subject Navigating Prescription Medication Access & Patient Support Programs
Date April 7, 2023 8:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Join us for an online forum (with Q&A) to that covers navigating access to prescription medications and overcoming the financial barriers.

View this email in your browser ([link removed])
[link removed]


** Online Forum:
------------------------------------------------------------


** Navigating Prescription Medication Access & Patient Support Programs
------------------------------------------------------------
[link removed]

Thursday, April 20, 2023
3-4 pm CST
Register ([link removed])

Navigating access to prescription medications and overcoming the financial barriers can be incredibly complex and frustrating. Join us for an informative virtual forum about the challenges to accessing prescription medications and cost-saving strategies. Phyllis Kidder, PharmD from Blue Fin Group, will discuss the key players in the prescription drug supply chain (e.g. manufacturers, pharmacy benefit managers, insurers, etc.), common barriers like prior authorizations and step edits, and different ways patients can access cost savings. Representatives from SK Life Sciences, Azurity Pharmaceuticals and Jazz Pharmaceuticals will give brief overviews of the programs they offer to support patients accessing their antiseizure medications, and then we will have plenty of time for Q&A. Come learn from experts and get some of your questions answered!

This online forum is brought to you through the generous support of SK Life Sciences, Azurity Pharmaceuticals, and Jazz Pharmaceuticals.
Register ([link removed])

Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed] [link removed] [link removed] [link removed] [link removed] [link removed]
[link removed]

Copyright (C) 2023 CURE Epilepsy. All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.
Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Want to change how you receive these emails?
You can update your preferences ([link removed]) or unsubscribe ([link removed])
Screenshot of the email generated on import

Message Analysis